AJP - Endo Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 268: E730-E734, 1995;
0193-1849/95 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hickson, R. C.
Right arrow Articles by Wegrzyn, L. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hickson, R. C.
Right arrow Articles by Wegrzyn, L. E.

AJP - Endocrinology and Metabolism, Vol 268, Issue 4 E730-E734, Copyright © 1995 by American Physiological Society


ARTICLES

Glutamine prevents downregulation of myosin heavy chain synthesis and muscle atrophy from glucocorticoids

R. C. Hickson, S. M. Czerwinski and L. E. Wegrzyn
School of Kinesiology (M/C194), University of Illinois at Chicago 60608-1516, USA.

The aims of this study were to determine whether glutamine infusion prevents the decline in protein synthesis and muscle wasting associated with repeated glucocorticoid treatment. Hormone (cortisol acetate, 100 mg.kg body wt-1.day-1) and vehicle (carboxymethyl cellulose)-treated female rats were infused with either saline or glutamine (240 mM, 0.75 ml/h) for a 7-day period. Glutamine infusion attenuated the decline of plantaris muscle glutamine concentration (3.0 +/- 0.2 vs. 2.3 +/- 0.2 mumol/g) and prevented > 70% of the total muscle mass losses due to the glucocorticoid injections. Fractional synthesis rates of myosin heavy chain (MHC) and total protein were determined after constant [3H]leucine infusion from the leucyl-tRNA precursor pool, which was similar in all groups (range 4.8 +/- 0.5 to 6.3 +/- 0.4 disintegrations.min-1.pmol-1). MHC synthesis rates (%/day) in plantaris muscles were reduced to approximately 40% of controls (4.2/9.4). Although glutamine had no effect on MHC synthesis in vehicle-treated animals (10.1/9.4), it prevented 50% (7.6/4.2) of the hormone-induced decline in MHC synthesis rates. The same results were obtained with total protein synthesis measurements. Changes in muscle mass did not appear related to estimates of protein breakdown. In conclusion, these data show that glutamine infusion is effective therapy in counteracting glucocorticoid-induced muscle atrophy. Atrophy attenuation appears related to maintaining muscle glutamine levels, which in turn may limit the glucocorticoid-mediated downregulation of MHC synthesis.


This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
L. G. Menezes, C. Sobreira, L. Neder, A. L. Rodrigues-Junior, and J. A. Baddini Martinez
Creatine supplementation attenuates corticosteroid-induced muscle wasting and impairment of exercise performance in rats
J Appl Physiol, February 1, 2007; 102(2): 698 - 703.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
V. R. Young and A. M. Ajami
Glutamine: The Emperor or His Clothes?
J. Nutr., September 1, 2001; 131(9): 2449S - 2459.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
B. Mittendorfer, E. Volpi, and R. R. Wolfe
Whole body and skeletal muscle glutamine metabolism in healthy subjects
Am J Physiol Endocrinol Metab, February 1, 2001; 280(2): E323 - E333.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online